Skip to main content

Clinical Trials Using Cisplatin

Review the clinical trials studying cisplatin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 151-175 of 203

Chemotherapy and Cemiplimab with or without Alirocumab before Surgery for the Treatment of Lung Cancer in Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Comparing two Chemotherapy Regimens (NALIRIFOX and mGAP) in the Treatment of Locally Advanced, Unresectable, and Metastatic Pancreatic Adenocarcinoma
Status: Active
Location: Medical University of South Carolina, Charleston, South Carolina
Intensity-Modulated Radiation Therapy in Treating Patients with HPV-Positive Oropharyngeal Cancer
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Y-90 SIRT in Combination with Durvalumab and Gemcitabine and Cisplatin for the Treatment of Locally Advanced, Unresectable, or Metastatic Biliary Tract Cancer
Status: Active
Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Involved Nodal Radiotherapy versus Elective Neck Radiotherapy for the Treatment of Stage I-IVB Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Cancer, The INVERT Trial
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Radiation Therapy in Reduced Dose and Hypofractionated Schedule after Trans-Oral Robotic Surgery to Improve Quality of Life in Patients with Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Cemiplimab with or without Chemotherapy followed by Biomarker Guided De-escalated Therapy for the Treatment of Patients with HPV-related Oropharyngeal Squamous Cell Cancer, MINIMA Trial
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Immunotherapy with or without Radiation Therapy for the Treatment of Patients with Advanced Unresectable Intrahepatic Cholangiocarcinoma, a HYPERION CCA Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Partial Cystectomy and Extended Pelvic Lymph Node Dissection with Standard of Care Systemic Therapy for the Treatment of Muscle-Invasive Bladder Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Radiation Therapy with Cisplatin or Docetaxel and Cetuximab in Treating Patients with Stage III-IVB Head and Neck Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Transoral Surgery followed by De-escalated IMRT with or without Cisplatin or Carboplatin for the Treatment of HPV-Positive Stage III, IVA, and IVB Oropharyngeal Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Response-Adaptive Chemoradiation after Induction Therapy for the Treatment of Patients with Locally Advanced Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, Clonal Cytopenia of Undetermined Significance and Chronic Myelomonocytic Leukemia
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Evaluating Unilateral Radiation Therapy with and without Cisplatin in Treating Patients with HPV 16+ Oropharyngeal Cancer
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
CTX-009, Gemcitabine, Cisplatin, and Durvalumab for the Treatment of Patients with Unresectable, Metastatic, or Recurrent Biliary Tract Cancers
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
External Beam Radiation Therapy and Brachytherapy with Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Status: Active
Location: 5 locations
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients with Soft Tissue Sarcoma, Bone Sarcoma, or Colorectal Cancer Metastatic to the Lungs
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Durvalumab and Tremelimumab with or without Chemotherapy for the Treatment of Potentially Resectable Pleural Mesothelioma
Status: Active
Location: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men with Stage II-III Metastatic Testicular Germ Cell Tumors
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Gemcitabine, Cisplatin, and Nab-Paclitaxel in Combination with Tumor Treatment Fields for the Treatment of Recurrent and/or Metastatic Pancreatic Cancer
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Hyperthermic Intraperitoneal Chemotherapy with Cisplatin After Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Chemoimmunotherapy Combined with Deep Hyperthermia and Spatially-fractionated Radiotherapy for the Treatment of Advanced Biliary Tract Cancer
Status: Active
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination with Gemcitabine, Cisplatin and Durvalumab for the Treatment of Biliary Tract Cancer Patients with Peritoneal Metastases
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Pembrolizumab in Combination with Chemotherapy and Image-Guided Surgery for the Treatment of Resectable Pleural Malignant Mesothelioma (MPM)
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania